Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML.

[1]  R. Strair,et al.  On Being Duped: Duplication of Chromosome 1 [Dup(1)(q21q32)] as the Sole Cytogenetic Abnormality In a Patient Previously Treated for AML , 2010 .

[2]  T. Haferlach,et al.  Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies. , 2009, Cancer genetics and cytogenetics.

[3]  J. Rosell,et al.  dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes. , 2008, Leukemia research.

[4]  J. Cigudosa,et al.  Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. , 2005, Haematologica.

[5]  A. Zelenetz,et al.  Molecular cytogenetic analysis of genomic instability at the 1q12–22 chromosomal site in B‐cell non‐Hodgkin lymphoma , 2002, Genes, chromosomes & cancer.

[6]  D. S. Lee,et al.  Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. , 2002, Cancer genetics and cytogenetics.

[7]  R. Berger,et al.  Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations , 1999, Leukemia.

[8]  Y. Kaneko,et al.  Minimal residual disease in acute monocytic leukemia patient with trisomy 11 and partial tandem duplication of MLL. , 1997, Cancer genetics and cytogenetics.

[9]  K. Ohyashiki,et al.  Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. , 1994, Cancer research.

[10]  S. Horiike,et al.  Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation. , 1994, Cancer genetics and cytogenetics.